Search results
Results from the WOW.Com Content Network
Initial use of ECMO in COVID-19 patients from China early in the pandemic suggested poor outcomes, with less than 90% mortality. [83] In March 2020, the ELSO registry began collecting data on the worldwide use of ECMO for patients with COVID-19 and reporting this data on the ELSO website in real time.
A similar set-up of temporary COVID-19 hospital has been widely adapted worldwide to offer treatment and disease monitoring to patients with mild symptoms. COVID-19 hospital is a general name given to clinical institutions that provide medical treatment to Coronavirus Disease 2019 (COVID-19) infected patients. [1]
Cardiologists are urging you—yes, you—to get up to date on your vaccinations this season, especially for COVID-19. That said, you don't need to panic necessarily (especially if you do get the ...
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]
Dr. Peter McCullough, a Texas cardiologist who promoted ivermectin as a treatment for COVID-19. Dr. James Thorp, an OB-GYN who wrote a book claiming the vaccine killed or injured hundreds of ...
Why a spike in COVID-19 cases largely driven by new variants doesn’t portend a return to the worst days of the pandemic.
In the United States, remdesivir is indicated for the treatment of COVID‑19 in people 28 days of age and older and weighing at least 3 kilograms (6.6 lb) who are hospitalized; or not hospitalized and have mild-to-moderate COVID‑19, and are at high risk for progression to severe COVID‑19, including hospitalization or death. [12] [26]
In July 2020, the European Medicines Agency (EMA) started reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID-19 admitted to the hospital to provide an opinion on the results. It focused particularly on the potential use of the drug for the treatment of adults with COVID-19.